GPT and Cirrhosis: The data from another nationwide real-life Korean study of 484 HBeAg-positive CHB patients with normal ALT levels (<40 U/L), high HBV DNA levels (>20,000 IU/mL), and no cirrhosis throw some light on this important yet difficult-to-analyze topic.